Recent media items include:
- In Law360, Life Sciences Attorneys Examine FDA’s Transition Plans for Medical Devices Under Emergency Use Authorizations and Enforcement Policies (January 20, 2022)
- In National Law Journal, Matt Rizzolo Discusses Lateral Moves in the ITC Bar (January 20, 2022)
- In Law360, Attorneys Analyze DOJ Civil Cyber-Fraud Initiative Impact on Health Care Companies (December 22, 2021)
- In Law360, Ed McNicholas Examines Top Data Privacy Developments of 2021 (December 22, 2021)
- Medtech Insight Discusses False Claims Act Focused Panel Moderated by Beth Weinman at FDLI Conference (December 16, 2021)
- In Fortune, Michael Littenberg Examines Alignment Toward Global ESG Standards (December 15, 2021)
- IP Litigators Analyze Section 112 Biopharma Post-Grant Review Patent Challenges (December 14, 2021)
- In ESG Investor, Michael Littenberg Discusses Timing of SEC Climate Change Rules (December 9, 2021)
- In Bloomberg Law, IP Litigators Examine U.S. DOJ Draft Standard-Patent Guidance (December 8, 2021)
- In Law360, IP Litigators Analyze Patent Eligibility Challenges at the International Trade Commission (November 30, 2021)
- Podcast: Non-binding Guidance: Rolling Back the Medicare Coverage of Innovative Technology (MCIT) Rule (November 8, 2021)
- In Financial Times Ignites, Craig Marcus Examines SEC Guidance Easing Path to Votes on Shareholder ESG Proposals (November 5, 2021)
- In Law360, Bloomberg Law and Reuters, Scott McKeown Discusses Biden Administration Nomination of PTO Director Kathi Vidal (October 28, 2021)
- In Food and Drug Law Journal, Jonathan Iwry Examines FDA Emergency Use Authorization Historical Lessons (October 25, 2021)
- In FinTech Law Report, DC Attorneys Analyze SEC Broad Theory of Required Disclosures of Security Incidents (October 25, 2021)
- In Food and Drug Law Journal, Attorneys Analyze COVID-19 Impact on American Medical Product Supply Chain and Initiatives to Strengthen Supply Chain Security (October 19, 2021)
- In Law360, Attorneys Analyze Takeaways from D.C. Circuit Medicare Advantage Overpayment Ruling (October 13, 2021)
- In New York Magazine’s The Cut, Mark Barnes Discusses the Biden Administration’s COVID-19 Vaccine Mandate for Workers (October 1, 2021)
- In Law360, IP Litigators Examine Three Patent Eligibility Reform Proposals (September 29, 2021)
- In Managing Intellectual Property, Scott McKeown Discusses Senator Patrick Leahy’s New PTAB Legislation (September 22, 2021)
- In Bloomberg Law, IP Litigators Analyze Potential Hurdles to U.S. Implementation of a COVID-19-Related IP Rights Waiver (September 16, 2021)
- In National Law Journal and Law360, Matt Rizzolo Examines Next International Trade Commission Administrative Law Judge (September 14, 2021)
- In Barron’s and USA Today, Mark Barnes Examines Whether President Biden’s New Vaccine Mandate Can Withstand Legal Challenges (September 13, 2021)
- Raffi Teperdjian Co-Authors Artificial Intelligence Article in The George Washington Law Review Arguendo (July 30, 2021)
- In Bloomberg Law, Paul Tropp Addresses SPAC Warrant Restatements and IPOs (July 26, 2021)
- In Law360 and AIPLA Webinar, Scott McKeown Addresses PTAB Discretionary Denials (July 22, 2021)
- In Westlaw Today, Attorneys Analyze Future of State Regulation of Pharmacy Benefit Managers Following U.S. Supreme Court Ruling (June 30, 2021)
- Scott McKeown Examines U.S. Supreme Court Patent Review Ruling (June 22, 2021)
- IP Attorneys Examine Non-Fungible Token Legal Issues in Legaltech News (June 3, 2021)
- Mark Barnes Examines Subject-Sponsor Interactions in Report on Research Compliance (June 1, 2021)
- Law.com Profiles Launch of Ropes & Gray’s Talkin’ Trade ITC Podcast (May 24, 2021)
- In Managing Intellectual Property, Steve Pepe Discusses DOJ’s Antitrust Division Action Toward Standards Implementers Under the Biden Administration (May 18, 2021)
- In Nasdaq Trade Talks Video, Paul Tropp Addresses State of SPAC Market (May 11, 2021)
- Health Care Attorneys Analyze the Future of Telehealth (May 11, 2021)
- Attorneys Examine FDA Enforcement Implications of U.S. Supreme Court Decision on Restitution and Disgorgement (May 6, 2021)
- In Law360, Paul Tropp Analyzes Slowdown in SPAC IPOs (May 6, 2021)
- Melissa Bender Talks about the Potential for a Federal Reserve-Backed Digital Currency (May 4, 2021)
- Capital Clubhouse Named Finalist in DC Congresswoman Eleanor Holmes Norton’s Community Project Funding Initiative (April 28, 2021)
- In Pensions & Investments, Michael Littenberg Analyzes the Tension of ESG Investment Factors with Geopolitics (April 20, 2021)
- In Bloomberg Law, Scott McKeown Examines Rise in Bank Lawsuits After Business Patent Reviews End (April 16, 2021)
- In Bloomberg Law, Attorneys Analyze Potential Costs of Reshoring Pharmaceutical Manufacturing (April 9, 2021)
- In Bloomberg Law, Kevin Post Analyzes FTC Strategy in Qualcomm Antitrust Litigation (April 5, 2021)
- What the U.S. Federal Government Might Learn from States About Regulating Drug Pricing (March 24, 2021)
- In Financial Times’ “The Banker,” Craig Marcus Addresses Legal Risks for Retail Investors in Social Media-led Rallies of ‘Meme Stocks’ (March 23, 2021)
- In New York Law Journal, IP Litigators Analyze Patent Valuation Methods Related to 5G Licensing for Internet of Things Products (March 22, 2021)
- Data Privacy Attorneys Author Chambers Cybersecurity Guide U.S. Chapter (March 18, 2021)
- In Journal of Robotics, Artificial Intelligence & Law, Attorneys Analyze Human Rights Compliance Guidance for Surveillance Capability Products (March 17, 2021)
- Ropes & Gray Ranked in Top Five Firms for Most PTAB Litigation Work in 2020 (March 11, 2021)
- Law360 Profiles Tara Fisher on Guiding Novavax in Pursuit of COVID-19 Vaccine (March 11, 2021)
- IP Litigator Matt Rizzolo Examines SCOTUS Oral Argument on Patent Judge Appointments (March 8, 2021)
- The Wall Street Journal Quotes Jeremiah Williams, Who Discusses SEC's Enforcement Priorities (March 4, 2021)
- In Law360, Margaux Hall Examines Drug Commercialization and Market Access Strategies in Light of Drug Pricing Regulatory Uncertainty Under the Biden Administration (February 16, 2021)
- In Managing Intellectual Property, IP Litigator Addresses Patent Eligibility Criteria Challenges (February 16, 2021)
- In The New York Times, Craig Marcus Examines How Certain Winners are Cashing in on ‘Meme Stock’ Mania (February 9, 2021)
- Massachusetts Lawyers Weekly, Attorneys Evaluate New Federal Trademark and Copyright Laws (January 20, 2021)
- In Managing IP, Peter Brody Analyzes Trademark Modernization Act (January 11, 2021)
- Health Care Co-Chairs Address Key Issues Facing Health Payers in 2021 (January 8, 2021)
- In Law360, IP Litigators Analyze Consequences of Federal Circuit Hatch-Waxman Patent Venue Ruling (January 7, 2021)
- In Law360, Tom Bulleit Analyzes 2021 Health Policies Under the Biden Administration (January 5, 2021)
- In Law360 and Bloomberg Law, Digital Health Initiative Attorneys Examine 2020 Trends and Provide 2021 Outlook (January 5, 2021)
- In Law360, Attorneys Evaluate 2021 IPO Market (January 5, 2021)
- In Law360, Peter Brody Analyzes Trademark Modernization Act in U.S. Congress Bill (December 22, 2020)
- In FDLI Update, Attorneys Examine Recent Trends for FDCA Injunctions (December 22, 2020)
- Bloomberg Law, IP Litigators Evaluate Licensing and Litigation of 5G Standard-Essential Patents (December 10, 2020)
- Ropes & Gray Launches Virtual Panel Discussion Series on 2020 Election Impact (December 8, 2020)
- In Bloomberg Law, Tom Bulleit Discusses New “Stark” and Anti-Kickback Rules for Value-Based Arrangements (November 25, 2020)
- In Law360, Health Care Attorneys Examine State Drug Pricing Reforms (November 25, 2020)
- In Law360, IP Litigators Discuss Federal Circuit Ruling on Patent Venue Statute and Hatch-Waxman Act (November 18, 2020)
- Ropes & Gray Successfully Defends Another GREE Patent from a PTAB Petition (November 13, 2020)
- In Law360, Attorneys Analyze Two HHS Opinions That Support Broad Immunity from COVID-19 Liability (November 10, 2020)
- In Law360, Attorneys Examine Change in FDA's Review Priorities for COVID-19 Lab-Developed Tests (October 22, 2020)
- In Bloomberg Law, Greg Levine Evaluates FDA Plans for Permanent COVID-19 Test Authorization (October 20, 2020)
- In Food and Drug Law Institute Update Magazine, Attorneys Track Drug and Device Enforcement During COVID-19 (October 6, 2020)
- In Law360, Health Care Attorneys Address President Trump’s Executive Order on International Reference Pricing for Medicare Drugs (September 29, 2020)
- Ropes & Gray Honored With Three LMG 2020 Life Sciences Awards (September 24, 2020)
- In Law360, IP Litigators Examine Bill Curtailing Patent Troll Lawsuits at ITC (September 17, 2020)
- In Law360, Tom Bulleit Examines Trump’s Latest Drug Pricing Executive Order (September 15, 2020)
- In Law360, LSRC Attorneys Examine HHS Announcement Barring FDA from Requiring Premarket Review for Laboratory-Developed Tests (September 2, 2020)